The results demonstrated that among these factors, TRAF3 remained an independent predictor of a favorable prognosis in glioma, with elevated TRAF3 expression consistently correlating with improved survival outcomes, regardless of other clinical and genetic variables (Supplemental Figure 1C). The gene discussed is TRAF3; the disease is glioma.